Australians trial Botox to treat hay fever

October 9, 2012

The best-selling wrinkle erasing drug Botox will be used in an Australian study to treat hay fever, researchers said Tuesday after it showed promise in providing relief in early trials.

Philip Bardin, a professor at the Monash Medical Centre which is linked to Melbourne's Monash University, said Botox was already widely used in medicine to reduce spasms in muscles following strokes and in treating cerebral palsy.

"This is very new way to use an old medication," he said.

Under the trial, a Botox gel will be applied to the nose to hopefully give hay fever sufferers relief from sneezing, itchy eyes and runny noses for up to three months.

"Part of why this is possible is that the Botox molecule has been re-engineered to be able to penetrate through the skin but also through the lining of the nose," Bardin told AFP.

"That's really the crucial development that has taken place. So consequently it is going to be possible in the future to extend its use from being mostly a cosmetic product... to become possibly even more useful."

In treating hay fever, the will affect the nerves in the nose and potentially block some of the chemicals released by the which play a large role in causing symptoms, he said.

Seventy people will be recruited for the study following a preliminary trial that suggested the drug provided relief.

Botox, which makes muscles relax, is a purified form of a produced by a bacteria that causes a disease which paralyses muscles and can be fatal.

It was first used to treat disorders of the —uncontrollable blinking and misaligned eyes.

Its cosmetic use took off in the 1990s after a Canadian noticed her patients were losing their frown lines after using the medication.

Related Stories

US approves Botox for bladder control

August 24, 2011

The face-freezing pharmaceutical injection Botox gained another medical use on Wednesday when the US government approved it for use in some patients with overactive bladder.

Botox developer rues missing out on billions

February 13, 2012

Botox developer Alan Scott says he rues the day he handed over rights to the best-selling wrinkle-smoothing drug to a US company for just $4.5 million, saying he might have become a billionaire.

Recommended for you

Experimental MERS vaccine shows promise in animal studies

July 28, 2015

A two-step regimen of experimental vaccines against Middle East respiratory syndrome (MERS) prompted immune responses in mice and rhesus macaques, report National Institutes of Health scientists who designed the vaccines. ...

Can social isolation fuel epidemics?

July 21, 2015

Conventional wisdom has it that the more people stay within their own social groups and avoid others, the less likely it is small disease outbreaks turn into full-blown epidemics. But the conventional wisdom is wrong, according ...

Lack of knowledge on animal disease leaves humans at risk

July 20, 2015

Researchers from the University of Sydney have painted the most detailed picture to date of major infectious diseases shared between wildlife and livestock, and found a huge gap in knowledge about diseases which could spread ...

IBD genetically similar in Europeans and non-Europeans

July 20, 2015

The first genetic study of inflammatory bowel disease (IBD) to include individuals from diverse populations has shown that the regions of the genome underlying the disease are consistent around the world. This study, conducted ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.